Suppr超能文献

在搅拌悬浮培养中,脐带血长期培养起始细胞实现了8倍的体外扩增。

An eight-fold ex vivo expansion of long-term culture-initiating cells from umbilical cord blood in stirred suspension cultures.

作者信息

Kögler G, Callejas J, Sorg R V, Wernet P

机构信息

Bone Marrow Donor Center with Eurocord Bank Germany and Transplantation Immunology, Heinrich Heine University, Düsseldorf.

出版信息

Bone Marrow Transplant. 1998 Jun;21 Suppl 3:S48-53.

PMID:9712494
Abstract

Simultaneous ex vivo expansion of different progenitor cell types may be beneficial for cord blood (CB) transplantation, to overcome a potential limitation due to restricted cell numbers. Therefore, 1.5 x 10(6) CD34+ cells isolated from fresh or thawed CB samples were inoculated in a large-scale stirred suspension bioreactor and cultured in the presence of Flt3-L, SCF and IL-3. At days 0, 7, 10, 14, 21 and 28, the spinner cultures were analyzed for viable cells, colony-forming cells (CFC), including erythroid burst-forming unit (BFU-E), granulocyte-macrophage colony-forming unit (CFU-GM) and granulocyte-erythrocyte-megakaryocyte-monocyte colony-forming unit (CFU-GEMM) as well as long-term culture-initiating cells (LTC-IC). Expansion of thawed CD34+ cells resulted in a substantial amplification of total cells (maximal at day 28: 154 +/- 132-fold), CFC (maximal at day 14: 45 +/- 36-fold), CFU-GM (maximal at day 14: 88 +/- 85-fold), CFU-GEMM (maximal at day 7: 4 +/- 2-fold) and of LTC-IC (maximal at day 10: 8 +/- 3-fold). There was no significant difference between fresh and thawed CD34+ cells. These results demonstrate that simultaneously committed progenitors as well as the more immature CFU-GEMM and LTC-IC can be substantially amplified from CD34+-enriched CB samples in large-scale stirred suspension cultures within 7-14 days without exhausting the proliferative potential and, thus, it may be possible to improve CB transplantation by ex vivo generated cells.

摘要

同时对不同祖细胞类型进行体外扩增可能有利于脐带血(CB)移植,以克服因细胞数量有限而带来的潜在限制。因此,将从新鲜或解冻的CB样本中分离出的1.5×10⁶个CD34⁺细胞接种到大规模搅拌悬浮生物反应器中,并在Flt3-L、SCF和IL-3存在的情况下进行培养。在第0、7、10、14、21和28天,对旋转培养物进行活细胞、集落形成细胞(CFC)分析,包括红系爆式集落形成单位(BFU-E)、粒细胞-巨噬细胞集落形成单位(CFU-GM)和粒细胞-红细胞-巨核细胞-单核细胞集落形成单位(CFU-GEMM)以及长期培养起始细胞(LTC-IC)。解冻的CD34⁺细胞扩增导致总细胞大量增加(第28天最大:154±132倍)、CFC(第14天最大:45±36倍)、CFU-GM(第14天最大:88±85倍)、CFU-GEMM(第7天最大:4±2倍)和LTC-IC(第10天最大:8±3倍)。新鲜和解冻的CD34⁺细胞之间没有显著差异。这些结果表明,在7-14天内,在大规模搅拌悬浮培养中,可以从富含CD34⁺的CB样本中大量扩增同时定向的祖细胞以及更不成熟的CFU-GEMM和LTC-IC,而不会耗尽增殖潜力,因此,通过体外生成的细胞有可能改善CB移植。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验